glp-1 gip lilly LY3437943, a novel triple glucagon, GIP, and receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept FDA approves tirzepatide, Eli Lilly's

Standard vitamins have trouble getting into the brain because of the blood-brain barrier

GLP-1 drugs are expensive and there is no realistic way to provide access to all possible recipients through mandates and regulations

Research shows that free-form EAAs stimulate MPS to a greater degree per gram than equivalent amounts of intact protein. Because free-form EAAs require no digestion, they produce a rapid rise in plasma amino acid concentrations that drives EAA transport into muscle. This makes EAA supplementation a practical option for GLP-1 users who cannot reliably consume adequate whole-food proteinnot as a replacement for food protein, but as a targeted tool to fill gaps when appetite is suppressed

Doing so means that you are taking a more active role in your weight loss journey, and it can feel gratifying to record your injections

doi:10.1189/jlb.0103020

During long car rides or flights, flex your calves and ankles regularly